Home / Recalls / Pacira Pharmaceuticals, Inc. / D-0621-2020

D-0621-2020 Class II Terminated

Recalled by Pacira Pharmaceuticals, Inc. — San Diego, CA

Recall Details

Product Type: Drugs
Report Date: December 11, 2019
Initiation Date: November 21, 2019
Termination Date: June 3, 2020
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 910 20 mL vials

Product Description

EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,

Reason for Recall

Sub Potent Drug: Out of Specification (OOS)

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Pacira Lot #: 19-5002, Patheon manufacturer Lot #: 098214; Exp. Date: Dec 2019